SP Group (SPG) Q2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2023 earnings summary
9 Nov, 2026Executive summary
Q1 2023 revenue was DKK 707.3m, down 1.8% YoY; EBITDA was DKK 127.7m, down 1.6%. 2023 guidance was maintained.
Lower volumes and weaker macroeconomic activity weighed on sales, partly offset by acquired activities; management expected higher activity in H2.
Financial highlights
Net income was DKK 53.7m vs DKK 65.5m YoY; EBT fell 17.5% to DKK 68.4m.
EBIT declined 9.9% to DKK 78.1m; depreciation and amortization rose to DKK 49.6m from DKK 43.0m.
Diluted EPS was DKK 4.42 vs DKK 5.33 YoY.
Acquired activities contributed DKK 21.9m to revenue and DKK 5.6m to EBITDA; FX added DKK 3.3m to revenue.
Outlook and guidance
FY 2023 revenue growth guidance remained 5–15%, with EBITDA margin of 16–19% and EBT margin of 9–12%.
New solutions for healthcare, cleantech and food-related industries were expected to support growth; high investment levels were planned, especially in healthcare.
Higher depreciation and financial expenses were expected in 2023, reflecting prior investment and higher interest rates.
Latest events from SP Group
- Earnings weakened, but guidance held as cleantech growth and new projects offered support.SPG
Q3 2023 - Lower 2023 earnings, stronger operating cash flow, and cautious growth guidance for 2024.SPG
Q4 2023 - Q1 earnings and margins rose; FY guidance held despite uncertainty.SPG
Q1 2024 - Own-brand growth lifted H1 earnings and supported higher FY2024 guidance amid uncertainty.SPG
Q2 2024 - Own-brand growth lifted 9M EBITDA 38.1%; FY revenue growth guidance is 10–16%.SPG
Q3 2024 - Record revenue and margin growth in 2024, with strong outlook for 2025.SPG
Q4 2024 - H1 2025 saw lower sales and earnings, but margins and full-year outlook remain stable.SPG
Q2 2025 - Own-brand growth lifted 9M earnings as FY revenue guidance narrowed to 10%-16%.SPG
Q3 2024 - Q1 2025 saw 8.8% revenue growth, strong margins, and robust Healthcare segment gains.SPG
Q1 2025